Meta-analysis of B type natriuretic peptide and N-terminal pro B natriuretic peptide in the diagnosis of clinical heart failure and population screening for left ventricular systolic dysfunction.
about
Brain natriuretic peptide (BNP) may play a major role in risk stratification based on cerebral oxygen saturation by near-infrared spectroscopy in patients undergoing major cardiovascular surgeryFGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy.NT-ProBNP independently predicts long-term mortality in patients admitted for coronary angiography.N-Terminal Pro-B-type Natriuretic Peptide Levels in the Korean General PopulationThe effect of the brain-type natriuretic peptide single-nucleotide polymorphism rs198389 on test characteristics of common assaysAlterations of serum brain type natriuretic peptide (BNP) in patients with Crimean-Congo hemorrhagic feverRecommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.Trends in laboratory test volumes for Medicare Part B reimbursements, 2000-2010Left ventricular ejection fraction assessment in older adults: an adjunct to natriuretic peptide testing to identify risk of new-onset heart failure and cardiovascular death?Chronic heart failure: we are fighting the battle, but are we winning the war?Natriuretic peptide testing in primary care patients.Old and new biomarkers of heart failure.Natriuretic peptides in the diagnosis and management of chronic heart failure.New and emerging biomarkers of heart failure.The paradox of low BNP levels in obesity.Measurement of the pro-hormone of brain type natriuretic peptide (proBNP): methodological considerations and pathophysiological relevance.State of the art of immunoassay methods for B-type natriuretic peptides: An update.Hemoglobin Concentration Influences N-Terminal Pro B-Type Natriuretic Peptide Levels in Hospitalized Older Adults with and without Heart Failure.Screening and intervention for treatment-related cardiac dysfunction in childhood cancer survivors.Korean Guidelines for Diagnosis and Management of Chronic Heart Failure.The Evolution of mHealth Solutions for Heart Failure Management.Association between electrocardiographic and echocardiographic markers of stage B heart failure and cardiovascular outcome.Proficiency testing project for brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP (NT-proBNP) immunoassays: the CardioOrmocheck study.Natriuretic peptides as indicators of cardiac remodeling in hypertensive patients.In-hospital worsening heart failure: a clinically relevant endpoint?CSI position statement on management of heart failure in India
P2860
Q33898609-C278B533-C49E-4E2F-B8EF-52EAA49F91B6Q34035797-EEE3FFD7-5D7F-4370-A90A-289C46C39824Q34306307-31187BA4-3ECF-446E-BC1F-1A027F205F9DQ34512556-B684E373-57C5-4087-8102-DBFEF5416229Q34616035-705AA48B-AC2E-43DF-BF48-EC4B2001BCC0Q35481345-3043068A-204B-49B6-91B3-1D1C2ED895E5Q35797623-3F70A073-328B-467B-A5B8-3EC24B99F560Q36423616-3E255AFF-002B-4DA0-9460-90CFC508A978Q36520069-E199DDB7-A5F9-4B71-84C5-B55C5A684276Q37288386-A089CE38-4E65-4DA4-A8C4-2FFDE6B4EEACQ37291305-86F21963-D340-42B2-AAD3-0C3F97B12B3FQ37426212-D98F5FC7-B427-4664-B756-C72F53A5E747Q37447544-DD8436EA-2300-48BA-A93D-47E52C08FF20Q37514230-87753570-6B71-4BED-A451-B75A9F19F816Q37869374-47B1A47C-B06B-4B4D-9A35-FF9A0420BC52Q37922195-F08F7727-CBFB-498F-BE8B-2D32CAB30B37Q38303192-66443B5E-322C-4578-B79D-5CAC78412092Q38757052-AE5116F0-0FF1-4A07-A837-6F4ECB4B6E12Q38982295-A111F1AE-3F35-4B9A-B43A-4FC11AAF7BD0Q41686228-BACB2A5A-9728-4670-B4D2-59CB68684467Q46294395-0DE68738-E4F3-4EFE-85AA-C0F95B4E9D99Q47703896-8DF1462F-1B67-4959-9122-3B063152A470Q47918086-C2B9FD45-FA10-421A-BE03-4EF672C3F28DQ48548331-DA7580A5-5767-4DF9-BC2F-A8A49978876DQ49315002-DD9F2655-2D6F-4F9C-A5AC-BC4994C4A8AFQ57665132-97B9EADC-3F24-4998-8992-D32F682D8ECC
P2860
Meta-analysis of B type natriuretic peptide and N-terminal pro B natriuretic peptide in the diagnosis of clinical heart failure and population screening for left ventricular systolic dysfunction.
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Meta-analysis of B type natriu ...... tricular systolic dysfunction.
@ast
Meta-analysis of B type natriu ...... tricular systolic dysfunction.
@en
Meta-analysis of B type natriu ...... tricular systolic dysfunction.
@nl
type
label
Meta-analysis of B type natriu ...... tricular systolic dysfunction.
@ast
Meta-analysis of B type natriu ...... tricular systolic dysfunction.
@en
Meta-analysis of B type natriu ...... tricular systolic dysfunction.
@nl
prefLabel
Meta-analysis of B type natriu ...... tricular systolic dysfunction.
@ast
Meta-analysis of B type natriu ...... tricular systolic dysfunction.
@en
Meta-analysis of B type natriu ...... tricular systolic dysfunction.
@nl
P2093
P2860
P921
P1476
Meta-analysis of B type natriu ...... tricular systolic dysfunction.
@en
P2093
P2860
P304
P356
10.1111/J.1445-5994.2007.01454.X
P50
P577
2008-02-01T00:00:00Z